Estimates Revisions Sensorion

Stocks

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-12 EDT			5-day change	1st Jan Change
0.2600 ^EUR	-6.64%		-32.82%	-22.85%

06-11	Sensorion continues its decline despite Stifel's positive outlook
06-10	Sensorion Achieves Key Regulatory Milestones for Sens-601 for Gjb2-Related Hearing Loss and Selects Program as Lead Gene Therapy Candidate	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	SENSORION
	LONZA GROUP AG
	REVOLUTION MEDICINES, INC.
	IQVIA HOLDINGS INC.
	BEONE MEDICINES AG
	CELLTRION, INC.
	MEDPACE HOLDINGS, INC.
	EUROFINS SCIENTIFIC SE
	ASCENDIS PHARMA A/S			-
	IONIS PHARMACEUTICALS, INC.
	Average
	Weighted average by Cap.